Min Li | DNA Sequencing | Best Researcher Award

Posted on 18/11/202418/11/2024 by PencisLeave a Comment

Dr. Min Li | DNA Sequencing | Best Researcher Award

Guangxi University | China

Author Profile

🏫 EARLY ACADEMIC PURSUITS

Min Li embarked on her academic journey with a Bachelor’s degree in Biotechnology from Southwest Forestry University (2008–2009). Demonstrating an early interest in plant biology, she pursued her Ph.D. in Crop Genetics and Breeding at Guangxi University (2015–2020), where she developed expertise in cotton genetics and CMS mechanisms. Her doctoral research laid the foundation for her impactful career in plant genomics.

💼 PROFESSIONAL ENDEAVORS

Min Li is currently a Postdoctoral Fellow at Guangxi University. During her postdoctoral fellowship, she has delved deeper into the molecular biology of CMS, focusing on its application in cotton breeding. Her collaborative work and independent projects have solidified her role as a key contributor in the field of plant genetics.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DNA SEQUENCING

Min Li’s research is centered on:

Molecular Mechanisms of Cytoplasmic Male Sterility (CMS):
She explores the genetic basis of CMS in cotton (Gossypium hirsutum L.), identifying and characterizing CMS-associated genes critical for hybrid seed production.
Functional Validation of Genes:
Her work extends to validating the roles of CMS genes in male sterility and fertility restoration, offering practical insights for breeding programs.
Hybrid Cotton Breeding:
Min Li’s contributions aim to enhance the efficiency and sustainability of hybrid seed production, addressing challenges in global agriculture.

🌍 IMPACT AND INFLUENCE

Min Li’s research is instrumental in understanding CMS at a molecular level, contributing to breakthroughs in hybrid breeding technologies. Her work supports the development of high-yielding, stress-resistant cotton varieties, significantly impacting agricultural productivity and sustainability.

📚 ACADEMIC CITES

Min Li has authored several influential publications in the field of plant genetics. Her works are widely cited, reflecting her contributions to advancing CMS research. She has also collaborated on major projects funded by prominent organizations, adding to her academic footprint.

🏆 RESEARCH GRANTS AND FUNDING

Min Li has successfully secured and participated in various prestigious research projects, including:

Principal Investigator:
- Guangxi Natural Science Foundation of China, 2022GXNSFBA035451 (2022–2025).
- China Postdoctoral Science Foundation, 2021MD703812 (2021–2023).
Collaborator:
- National Natural Science Foundation of China, Regional Science Fund Project (2021–2024).
- Guangxi Natural Science Foundation of China, 2017GXNSFA198023 (2017–2020).

🧬 LEGACY AND FUTURE CONTRIBUTIONS

Min Li envisions leveraging her expertise to further explore genetic mechanisms in plants, with a focus on translating molecular insights into practical breeding applications. Her research has the potential to revolutionize hybrid seed technologies, making agriculture more efficient and resilient to environmental challenges. Her legacy lies in her dedication to understanding and addressing complex genetic challenges, and she continues to inspire the next generation of researchers in plant genetics and genomics.

🌟 A VISIONARY IN COTTON GENETICS

Min Li’s career exemplifies the profound impact of innovative research in genetics and genomics. Through her work, she has positioned herself as a trailblazer in unraveling the complexities of plant molecular biology, paving the way for transformative advancements in global agriculture.

📑 NOTABLE PUBLICATIONS

"Impact of lignin on the starch accumulation, composition, and pasting properties of cassava"

Authors: Cai, Z. , Li, M. , Zhang, F. , Ye, W.-T. , Fan, X.-W.
Journal: LWT
Year: 2023

"LC–MS/MS-based metabolomics approach revealed novel phytocompounds from sugarcane rind with promising pharmacological value"

Authors: Rao, M.J. , Duan, M. , Wei, X. , Hu, L. , Wang, L.
Journal: Journal of the Science of Food and Agriculture
Year: 2022

"Sugarcane Rind Secondary Metabolites and Their Antioxidant Activities in Eleven Cultivated Sugarcane Varieties"

Authors: Rao, M.J. , Duan, M. , Yang, M. , Li, M. , Wang, L.
Journal: Sugar Tech
Year: 2022

"Genome-Wide Transcriptomic Analysis Reveals the Gene Regulatory Network Controlled by SRL1 in Regulating Rice Leaf Rolling"

Authors: Li, M. , Li, X. , Zhu, L. , Jin, J. , Wang, J.
Journal: Journal of Plant Growth Regulation
Year: 2022

"Transcriptomic and Widely Targeted Metabolomic Approach Identified Diverse Group of Bioactive Compounds, Antiradical Activities, and Their Associated Genes in Six Sugarcane Varieties"

Authors: Rao, M.J. , Duan, M. , Wang, J. , Hu, L. , Wang, L.
Journal: Antioxidants
Year: 2022

Anish Maskey | Staphylococcus Aureus | Best Researcher Award

Posted on 08/11/202408/11/2024 by PencisLeave a Comment

Dr. Anish Maskey | Staphylococcus Aureus | Best Researcher Award

New York Medical College | United States

Author Profile

Scopus

Orcid ID

Google Scholar

🌟 Dr. Anish R. Maskey, Ph.D. - Postdoctoral Fellow and Immunology Innovator

📚 EARLY ACADEMIC PURSUITS

Dr. Anish R. Maskey's academic journey began in Kathmandu, Nepal, where he earned a Bachelor of Science in 2016 from the Institute of Medicine. With a robust foundation in science, he pursued a Ph.D. in Pathology, Microbiology, and Immunology at New York Medical College, achieving an impressive CGPA of 3.75/4. His early education set the stage for a distinguished career in immunology, preparing him to tackle complex health challenges with innovative research approaches.

🧪 PROFESSIONAL ENDEAVORS

Currently a Postdoctoral Fellow in the Department of Pathology, Microbiology, and Immunology at New York Medical College, Dr. Maskey is mentored by Dr. Xiu-Min Li and focuses on pioneering research in immunology. His professional roles have spanned several collaborative and high-impact projects, including co-investigating clinical biomarker studies and leading efforts in immuno-oncology research related to chronic inflammatory and infectious diseases. Dr. Maskey’s work is characterized by his adept handling of sophisticated scientific techniques and a commitment to developing therapeutic strategies for challenging medical conditions.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON STAPHYLOCOCCUS AUREUS

Dr. Maskey's research contributions are extensive, with key focuses including:

B and T Cell Immunology: He has a deep-rooted expertise in investigating immune responses, particularly in relation to B and T cell functions in chronic inflammatory diseases and immuno-oncology.
Biomarker Studies in Allergy and Inflammation: His work on Traditional Chinese Medicine (TCM) involves understanding immune response markers in allergic diseases, the role of cytokines, and immune regulation, potentially offering new therapies for conditions such as eczema and food allergies.
Natural Compounds Against Antibiotic-Resistant Bacteria: In his role as Co-Principal Investigator, he has advanced research into natural compounds to combat antibiotic-resistant Staphylococcus aureus in both murine and humanized models.
Nanoparticle Immunotherapy: Dr. Maskey's study of berberine nanoparticles is pivotal in food allergy research, exploring mechanisms to suppress IgE-mediated allergic responses.

🌍 IMPACT AND INFLUENCE

Dr. Maskey's influence extends beyond the lab. His dedication to innovative research has earned him recognition through numerous awards, such as the AAAAI Ph.D. Travel Scholarships (2022-2024), the ASBMB Travel Award, and commendations for his scientific presentations. His involvement in conferences has facilitated cross-border collaborations, particularly between the U.S., India, and China, emphasizing his commitment to global health solutions. He is actively involved with organizations like the American Society for Microbiology and the American Academy of Allergy, Asthma, and Immunology, reflecting his dedication to community and professional engagement in the immunology field.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

With his research published in high-impact journals, Dr. Maskey's contributions to immunology are recognized and respected. He has authored numerous papers and serves as a peer reviewer for journals like The FASEB Journal, Cell Press, and Dove Medical Press. His scholarly output includes first-author publications, institutional presentations, and national conference contributions, underscoring his commitment to advancing immunology research.

🏅 HONORS & AWARDS

AAAAI Ph.D. Travel Scholarship (2022-2024)
Outstanding Abstract Award at Touro Research Day (2024)
Science in a Flash Runner-Up by ASBMB (2022)
Outstanding Scientific Poster at MIT's Future of Health Technology Summit (2019)

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Maskey’s legacy in immunology is still unfolding, with his promising work paving the way for future advancements in immunotherapy and natural medicine. His research on TCM, immune biomarkers, and nanoparticle technology is expected to yield novel treatment methods for allergies, chronic inflammation, and infectious diseases. Additionally, his role as a mentor to young scientists and his involvement in developing educational materials ensure his impact will resonate through future generations of researchers and clinicians.

🌠 FINAL NOTE

Dr. Anish R. Maskey embodies the spirit of a dedicated scientist and innovator, leveraging his expertise to improve human health. His work in immunology and microbiology is not only a testament to his skill but also his passion for creating lasting changes in medicine and science. With a promising future, Dr. Maskey continues to contribute meaningfully to the scientific community and inspire his peers and students alike.

📑 NOTABLE PUBLICATIONS

"Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways"

Authors: Maskey, A.R. , Kopulos, D. , Kwan, M. , Geliebter, J. , Li, X.-M.
Journal: Cells
Year: 2024

"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations"

Authors: Maskey, A.R. , Mo, X. , Li, X.-M.
Journal: Journal of Inflammation Research
Year: 2024

"The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation"

Authors: Wang, Z.-Z. , Li, H. , Maskey, A.R. , Sampson, H.A. , Li, X.-M.
Journal: Journal of Inflammation Research
Year: 2024

"Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell"

Authors: Yang, N. , Srivastava, K. , Chen, Y. , Zhan, J. , Li, X.-M.
Journal: Frontiers in Immunology
Year: 2024

"Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation"

Authors: Yang, N. , Maskey, A.R. , Srivastava, K. , Sampson, H.A. , Li, X.-M.
Journal: Frontiers in Immunology
Year: 2023

Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Posted on 25/09/202425/09/2024 by PencisLeave a Comment

Dr. Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

University of Buea | Cameroon

Author Profile

Scopus

Biography of Dr. Ofon Elvis Amih 🌍🧬

EARLY ACADEMIC PURSUITS 🎓

Dr. Ofon Elvis Amih’s academic journey is rooted in his commitment to biochemistry, starting with his undergraduate studies at the University of Dschang, Cameroon. From 2006 to 2010, he pursued a Bachelor of Science in Biochemistry with a specialty in Clinical Biochemistry. His passion for this field led him to continue his studies at the same institution, where he earned a Master of Science in Biochemistry between 2010 and 2013, further specializing in Clinical Biochemistry. In 2014, Dr. Amih embarked on his doctoral studies, culminating in a PhD in Biochemistry with a specialty in Clinical Biochemistry from the University of Dschang in 2019. His doctoral research solidified his expertise in biochemistry and set the stage for his future contributions to the field.

PROFESSIONAL ENDEAVORS AND TEACHING 📚

Dr. Amih’s career in academia began at the University of Dschang, where he served as a Graduate Teaching Monitor from 2014 to 2021. In this role, he assisted in tutorials, practical lessons, and exam invigilation. His teaching career advanced further when he joined the University of Buea as an Assistant Lecturer at the Faculty of Health Sciences in October 2021. His work at the University of Buea involves mentoring students and imparting valuable knowledge in the field of biochemistry. In addition to teaching, Dr. Amih engaged in postdoctoral research with the TrypanoGEN+ Consortium from 2019 to 2022, where he worked on groundbreaking research related to genome-wide association studies (GWAS). Furthermore, he became a Bioinformatics Fellow with H3Abionet/H3Africa, contributing to the intersection of bioinformatics and biochemistry through collaborative projects across Africa.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🔬

Dr. Amih's research is deeply focused on the genetic markers associated with Human African Trypanosomiasis (HAT). His manuscript, currently in press, titled "A Genome-wide association study reveals novel genetic markers associated with Human African Trypanosomiasis," marks a significant contribution to understanding this tropical disease. His research work bridges biochemistry and bioinformatics, with an emphasis on using advanced genomic tools to address pressing health issues in Africa.

IMPACT AND INFLUENCE 🌟

Dr. Amih has had a considerable influence in his field, particularly through his involvement in internationally recognized initiatives like the TrypanoGEN+ Consortium and H3Abionet/H3Africa. His contributions extend beyond research, as he is also shaping future generations of scientists and biochemists through his academic roles. His work has impacted the global scientific community, with his insights contributing to scientific journals and conferences worldwide. He has actively participated in numerous workshops and conferences, from local events in Cameroon to international collaborations, such as the H3ABioNet Online ‘Introduction to Bioinformatics’ training course in South Africa.

ACADEMIC CITATIONS AND PUBLICATIONS🏅

Dr. Amih’s academic impact is further validated by his involvement in journal review activities for reputable publications such as Plos Computational Biology and the Journal of Bioscience and Medicine. His own manuscripts, particularly the upcoming publication on genetic markers for Human African Trypanosomiasis, are anticipated to contribute valuable citations in the field of clinical biochemistry and tropical disease research.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

As Dr. Amih continues his academic and research endeavors, his legacy is likely to be defined by his contributions to both biochemistry and bioinformatics. His ongoing role at the University of Buea, coupled with his research collaborations across Africa, ensures that his work will leave a lasting impact on the scientific community, particularly in the areas of neglected tropical diseases and genetic research. Looking ahead, Dr. Amih is poised to expand his contributions through more collaborative research projects, potentially leading future generations of scientists and continuing to address critical health challenges in Africa. His deep expertise in both biochemistry and bioinformatics uniquely positions him as a leader in these intertwined disciplines.

NOTABLE PUBLICATIONS 📑

"High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation"

Authors: Mulindwa, J., Noyes, H., Ilboudo, H., Ahouty, B., & Kabore, J.
Journal: Human Genetics
Year: 2020

"Copy number variation in human genomes from three major ethno-linguistic groups in Africa"

Authors: Nyangiri, O.A. , Noyes, H. , Mulindwa, J. ,Hertz-Fowler, C. , Matovu, E.
Journal: Genomics
Year: 2020

"Molecular identification of different trypanosome species in tsetse flies caught in the wildlife reserve of Santchou in the western region of Cameroon"

Authors: Kamdem, C.N. , Tiofack, A.A.Z. , Mewamba, E.M. , Gomseu, E.B.D. , Simo, G.
Journal: Parasitology Research
Year: 2020

"Association between polymorphisms of IL4, IL13, IL10, STAT6 and IFNG genes, cytokines and immunoglobulin E levels with high burden of Schistosoma mansoni in children from schistosomiasis endemic areas of Cameroon"

Authors: Mewamba, E.M. , Noyes, H. , Tiofack, A.A.Z. , MacLeod, A. , Simo, G.
Journal: Genetics and Evolution
Year: 2023

"Evaluation of ITS1 rDNA primers for the detection and identification of African trypanosomes in mammalian hosts and tsetse flies."

Authors: Ofon, E.A. , Metiadjoue, M.C.C. , Kante, S.T. ,Fogue, S.P. , Simo, G.
Journal: Acta Tropica
Year: 2024

Bin Zhang | Gene Mutation | Best Researcher Award

Posted on 26/05/202426/05/2024 by PencisLeave a Comment

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024